touchPODCAST

Early diagnosis and treatment of NMOSD: Practical insights

touchIN CONVERSATION for touchOPTHAMOLOGY

Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.

The experts:

• Prof. John Chen - Mayo Clinic, Rochester, MN, USA
• Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchophthalmologyime.org/nmosd_diagnosis_treatment
https://touchneurologyime.org/nmosd_diagnosis_treatment

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 1 touchHAEMATOLOGY

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchHAEMATOLOGY

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Pathologist: Dr Eric Gars, Gainesville, FL, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchHAEMATOLOGY

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. 

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
• Critical care pharmacist: Prof. Rob MacLaren, Denver, CO

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchHAEMATOLOGY

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting Best practice for the multidisciplinary team - Part 1 touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Pathologist: Dr Eric Gars, Gainesville, FL, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. 

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
• Critical care pharmacist: Prof. Rob MacLaren, Denver, CO

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchIMMUNOLOGY

touchMDT for touchIMMUNOLOGY

Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
• Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

Let’s talk about agitation in Alzheimer’s dementia: Prevalence, behavioural symptoms and reaching a diagnosis

touchIN CONVERSATION for touchNEUROLOGY

Listen to Dr Carolyn Clevenger, a gerontological nurse practitioner, in conversation with family care partner Ms Kathleen Rhyne. They respond to questions submitted by the HCP audience, providing valuable insights on agitation in Alzheimer’s dementia with a focus on prevalence, behavioural symptoms and the importance of early recognition and diagnosis.

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).

For further information visit our website: https://touchneurology.com/education/mdt-perspectives-on-management-of-agitation-in-alzheimers-dementia/in-conversation-lets-talk-about-AAD/